These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38658125)

  • 1. New Diagnostic Criteria for Pulmonary Hypertension: Impact on Survival Prognostication Following Transcatheter Tricuspid Valve Intervention.
    Fortmeier V; Körber MI; Rommel KP; Stolz L; Kassar M; Praz F; Pfister R; Hausleiter J; Lurz P; Rudolph V
    JACC Cardiovasc Interv; 2024 Apr; 17(8):1073-1075. PubMed ID: 38658125
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute and Short-Term Results of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation Using the MitraClip XTR System.
    Braun D; Rommel KP; Orban M; Karam N; Brinkmann I; Besler C; Massberg S; Nabauer M; Lurz P; Hausleiter J
    JACC Cardiovasc Interv; 2019 Mar; 12(6):604-605. PubMed ID: 30898258
    [No Abstract]   [Full Text] [Related]  

  • 3. The International Multicenter TriValve Registry: Which Patients Are Undergoing Transcatheter Tricuspid Repair?
    Taramasso M; Hahn RT; Alessandrini H; Latib A; Attinger-Toller A; Braun D; Brochet E; Connelly KA; Denti P; Deuschl F; Englmaier A; Fam N; Frerker C; Hausleiter J; Juliard JM; Kaple R; Kreidel F; Kuck KH; Kuwata S; Ancona M; Malasa M; Nazif T; Nickenig G; Nietlispach F; Pozzoli A; Schäfer U; Schofer J; Schueler R; Tang G; Vahanian A; Webb JG; Yzeiraj E; Maisano F; Leon MB
    JACC Cardiovasc Interv; 2017 Oct; 10(19):1982-1990. PubMed ID: 28982563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter therapies for tricuspid valve regurgitation.
    Zaccone G; Di Pasquale M; Fiorina C; Curello S; Metra M; Adamo M
    J Cardiovasc Med (Hagerstown); 2020 Dec; 21(12):964-974. PubMed ID: 32858624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated tricuspid valve regurgitation: old concepts, new insights and innovation.
    Russo M; Zilberszac R; Werner P; Kocher A; Wiedemann D; Schneider M; Mascherbauer J; Laufer G; Rosenhek R; Andreas M
    J Cardiovasc Med (Hagerstown); 2020 Jun; 21(6):406-414. PubMed ID: 32073432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Outcomes of the FORMA Transcatheter Tricuspid Valve Repair System for the Treatment of Severe Tricuspid Regurgitation: Insights From the First-in-Human Experience.
    Asmarats L; Perlman G; Praz F; Hensey M; Chrissoheris MP; Philippon F; Ofek H; Ye J; Puri R; Pibarot P; Attinger A; Moss R; Bédard E; Moschovitis A; Reineke D; Lauck S; Blanke P; Leipsic J; Spargias K; Windecker S; Webb JG; Rodés-Cabau J
    JACC Cardiovasc Interv; 2019 Aug; 12(15):1438-1447. PubMed ID: 31395213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter interventions for tricuspid regurgitation: TriCinch (4Tech).
    Rosser BA; Taramasso M; Maisano F
    EuroIntervention; 2016 Sep; 12(Y):Y110-2. PubMed ID: 27640020
    [No Abstract]   [Full Text] [Related]  

  • 8. Transcatheter interventions for tricuspid regurgitation: the FORMA Repair System.
    Puri R; Rodés-Cabau J
    EuroIntervention; 2016 Sep; 12(Y):Y113-5. PubMed ID: 27640021
    [No Abstract]   [Full Text] [Related]  

  • 9. Transcatheter interventions for tricuspid regurgitation: MitraClip.
    Schueler R; Malasa M; Hammerstingl C; Nickenig G
    EuroIntervention; 2016 Sep; 12(Y):Y108-9. PubMed ID: 27640019
    [No Abstract]   [Full Text] [Related]  

  • 10. First-in-Man Experience of Transcatheter Tricuspid Valve Replacement With LuX-Valve in High-Risk Tricuspid Regurgitation Patients.
    Lu FL; Ma Y; An Z; Cai CL; Li BL; Song ZG; Han L; Wang J; Qiao F; Xu ZY
    JACC Cardiovasc Interv; 2020 Jul; 13(13):1614-1616. PubMed ID: 32646711
    [No Abstract]   [Full Text] [Related]  

  • 11. Transcatheter interventions for tricuspid regurgitation: Trialign and Mitralign.
    Schofer J
    EuroIntervention; 2016 Sep; 12(Y):Y119-20. PubMed ID: 27640023
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of Massive or Torrential Tricuspid Regurgitation in Patients Undergoing Transcatheter Tricuspid Valve Intervention.
    Miura M; Alessandrini H; Alkhodair A; Attinger-Toller A; Biasco L; Lurz P; Braun D; Brochet E; Connelly KA; de Bruijn S; Denti P; Deuschl F; Estevez-Loureiro R; Fam N; Frerker C; Gavazzoni M; Hausleiter J; Himbert D; Ho E; Juliard JM; Kaple R; Besler C; Kodali S; Kreidel F; Kuck KH; Latib A; Lauten A; Monivas V; Mehr M; Muntané-Carol G; Nazif T; Nickenig G; Pedrazzini G; Philippon F; Pozzoli A; Praz F; Puri R; Rodés-Cabau J; Schäfer U; Schofer J; Sievert H; Tang GHL; Thiele H; Rommel KP; Vahanian A; Von Bardeleben RS; Webb JG; Weber M; Windecker S; Winkel M; Zuber M; Leon MB; Maisano F; Hahn RT; Taramasso M;
    JACC Cardiovasc Interv; 2020 Sep; 13(17):1999-2009. PubMed ID: 32912460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter interventions for tricuspid regurgitation - heterotopic technology: TricValve.
    Figulla HR; Kiss K; Lauten A
    EuroIntervention; 2016 Sep; 12(Y):Y116-8. PubMed ID: 27640022
    [No Abstract]   [Full Text] [Related]  

  • 14. Interventional Treatment of Severe Tricuspid Regurgitation: Early Clinical Experience in a Multicenter, Observational, First-in-Man Study.
    Lauten A; Figulla HR; Unbehaun A; Fam N; Schofer J; Doenst T; Hausleiter J; Franz M; Jung C; Dreger H; Leistner D; Alushi B; Stundl A; Landmesser U; Falk V; Stangl K; Laule M
    Circ Cardiovasc Interv; 2018 Feb; 11(2):e006061. PubMed ID: 29445001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries.
    Mehr M; Karam N; Taramasso M; Ouarrak T; Schneider S; Lurz P; von Bardeleben RS; Fam N; Pozzoli A; Lubos E; Boekstegers P; Schillinger W; Plicht B; Eggebrecht H; Baldus S; Senges J; Maisano F; Hausleiter J;
    JACC Cardiovasc Interv; 2020 Mar; 13(5):543-550. PubMed ID: 31954679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Mitral and Tricuspid Versus Isolated Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Symptomatic Valve Regurgitation at High Surgical Risk.
    Besler C; Blazek S; Rommel KP; Noack T; von Roeder M; Luecke C; Seeburger J; Ender J; Borger MA; Linke A; Gutberlet M; Thiele H; Lurz P
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1142-1151. PubMed ID: 29929635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfemoral Transcatheter Tricuspid Valve Replacement.
    Fam NP; Ong G; Deva DP; Peterson MD
    JACC Cardiovasc Interv; 2020 May; 13(10):e93-e94. PubMed ID: 32171717
    [No Abstract]   [Full Text] [Related]  

  • 18. Causes and Outcomes of Ineligibility for Participation in a Transcatheter Tricuspid Clinical Trial.
    Sorajja P; Sato H; Walser-Kuntz E; Jappe K; Tindell L; Eckman PM; Cavalcante J; Bae R; Enriquez-Sarano M; Stanberry L; Hamid N
    JACC Cardiovasc Interv; 2024 Jun; 17(12):1514-1516. PubMed ID: 38925758
    [No Abstract]   [Full Text] [Related]  

  • 19. Percutaneous interventional options for the treatment of tricuspid regurgitation.
    Haude M; Prendergast B
    EuroIntervention; 2016 Sep; 12(Y):Y107. PubMed ID: 27640018
    [No Abstract]   [Full Text] [Related]  

  • 20. Residual Tricuspid Regurgitation After Intervention: Less Is More.
    Sitges M
    JACC Cardiovasc Interv; 2024 Jun; 17(12):1496-1497. PubMed ID: 38753453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.